Ebdarokimab (Anti-IL-12b)
Ebdarokimab (Anti-IL-12b) is a fully human monoclonal antibody (mAb) targeting Interleukin-12/Interleukin-23 (IL-12/IL-23) pathway. Ebdarokimab has the potential to treat moderate to severe plaque psoriasis. MW : 145.6 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2842 |
| Sku # | A2842-1mg*25 |
| Pricing | 1mg*25, $5070.00 |